1. Home
  2. IVVD vs HFRO Comparison

IVVD vs HFRO Comparison

Compare IVVD & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$0.90

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Logo Highland Opportunities and Income Fund of Beneficial Interest

HFRO

Highland Opportunities and Income Fund of Beneficial Interest

HOLD

Current Price

$7.47

Market Cap

393.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVVD
HFRO
Founded
2020
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
437.1M
393.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IVVD
HFRO
Price
$0.90
$7.47
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
6.4M
191.5K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
8.87%
EPS Growth
79.02
N/A
EPS
N/A
N/A
Revenue
$53,426,000.00
N/A
Revenue This Year
$61.57
N/A
Revenue Next Year
$41.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
110.47
N/A
52 Week Low
$0.49
$5.03
52 Week High
$3.07
$7.50

Technical Indicators

Market Signals
Indicator
IVVD
HFRO
Relative Strength Index (RSI) 42.00 68.58
Support Level $0.73 $6.23
Resistance Level $1.01 $7.50
Average True Range (ATR) 0.09 0.20
MACD 0.01 -0.01
Stochastic Oscillator 60.11 85.34

Price Performance

Historical Comparison
IVVD
HFRO

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About HFRO Highland Opportunities and Income Fund of Beneficial Interest

Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.

Share on Social Networks: